"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
MeSH Number(s)
B04.820.650.589.650.350.400
B04.909.777.731.589.650.350.400
Concept/Terms
HIV-1- HIV-1
- Immunodeficiency Virus Type 1, Human
- Human Immunodeficiency Virus Type 1
- HIV-I
- Human immunodeficiency virus 1
Below are MeSH descriptors whose meaning is more general than "HIV-1".
Below are MeSH descriptors whose meaning is more specific than "HIV-1".
This graph shows the total number of publications written about "HIV-1" by people in Harvard Catalyst Profiles by year, and whether "HIV-1" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 61 | 6 | 67 |
| 1992 | 75 | 5 | 80 |
| 1993 | 72 | 4 | 76 |
| 1994 | 82 | 8 | 90 |
| 1995 | 78 | 7 | 85 |
| 1996 | 100 | 4 | 104 |
| 1997 | 114 | 10 | 124 |
| 1998 | 127 | 11 | 138 |
| 1999 | 130 | 10 | 140 |
| 2000 | 132 | 22 | 154 |
| 2001 | 107 | 33 | 140 |
| 2002 | 108 | 20 | 128 |
| 2003 | 108 | 23 | 131 |
| 2004 | 111 | 19 | 130 |
| 2005 | 125 | 19 | 144 |
| 2006 | 132 | 34 | 166 |
| 2007 | 134 | 24 | 158 |
| 2008 | 125 | 37 | 162 |
| 2009 | 146 | 35 | 181 |
| 2010 | 160 | 35 | 195 |
| 2011 | 143 | 42 | 185 |
| 2012 | 181 | 44 | 225 |
| 2013 | 171 | 33 | 204 |
| 2014 | 155 | 35 | 190 |
| 2015 | 133 | 35 | 168 |
| 2016 | 117 | 26 | 143 |
| 2017 | 97 | 42 | 139 |
| 2018 | 112 | 30 | 142 |
| 2019 | 91 | 41 | 132 |
| 2020 | 76 | 35 | 111 |
| 2021 | 7 | 3 | 10 |
Below are the most recent publications written about "HIV-1" by people in Profiles.
-
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. N Engl J Med. 2021 03 18; 384(11):1003-1014.
-
The AMP Trials - A Glass Half Full. N Engl J Med. 2021 03 18; 384(11):1068-1069.
-
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques. Nat Commun. 2021 03 05; 12(1):1474.
-
Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial. Lancet HIV. 2021 03; 8(3):e130-e137.
-
Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus. J Infect Dis. 2021 02 13; 223(3):403-408.
-
Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa. AIDS. 2021 02 02; 35(2):205-211.
-
TRIGGERED: could refocused cell signaling be key to natural killer cell-based HIV immunotherapeutics? AIDS. 2021 02 02; 35(2):165-176.
-
Factors that mold the nuclear landscape of HIV-1 integration. Nucleic Acids Res. 2021 01 25; 49(2):621-635.
-
HIV Capsid and Integration Targeting. Viruses. 2021 Jan 18; 13(1).
-
Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions. J Virol. 2021 01 13; 95(3).